查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1956790

高通量DNA合成市场分析及预测（至2035年）：依类型、产品、服务、技术、组件、应用、形式、最终用户及製程划分

High Throughput DNA Synthesis Market Analysis and Forecast to 2035: Type, Product, Services, Technology, Component, Application, Form, End User, Process
出版日期: | 出版商: Global Insight Services | 英文 379 Pages | 商品交期: 3-5个工作天内

价格
简介目录

高通量DNA合成市场预计将从2024年的3.276亿美元成长到2034年的9.302亿美元，复合年增长率约为11.4%。高通量DNA合成市场涵盖了能够快速、经济高效地生产大规模DNA序列的技术。透过提供可扩展且精确的合成，该市场为合成生物学、药物发现和基因研究提供了支持。在自动化和生物资讯学进步的推动下，该市场正在满足对客製化DNA构建体日益增长的需求，从而促进医疗保健、农业和工业生物技术领域的创新。

受合成生物学和基因工程领域进步的推动，高通量DNA合成市场正经历强劲成长。寡核苷酸合成领域因其在治疗和诊断方面的应用而呈现最高成长率。基因合成是第二大成长领域，其成长动力来自对个人化医疗日益增长的需求以及基因组学研究的进步。自动化技术正在变革市场，提高DNA合成过程的效率并降低错误率。客製化DNA合成服务日益受到重视，以满足研究机构和生技公司的特定需求。製药和生物技术产业是市场扩张的主要促进者，这主要得益于DNA合成在药物开发和基因研究中的应用。创新的高通量合成平台不断涌现，为大规模计划提供可扩展的解决方案。研发投入的加速推动了新型合成技术的开发，并扩大了市场潜力。人工智慧（AI）和机器学习的融合有望进一步变革该产业。

市场区隔
类型 寡核苷酸合成、基因合成、客製化DNA合成
产品 合成设备、试剂与耗材
服务 基因编辑、克隆与定序
科技 固相合成、晶片合成、酵素合成
成分 酵素、核苷酸、缓衝溶液
目的 合成生物学、基因工程、分子诊断、药物发现
形式 液态冻干产品
最终用户 生技公司、製药公司、学术研究机构
流程 自动合成，手动合成

高通量DNA合成市场正经历剧烈的变革，大型生技公司占据了显着的市场份额。激烈的定价竞争和创新产品推出的涌现是当前市场格局的显着特征。新参与企业和老牌公司都在迅速推出先进的合成技术，以提高合成速度和准确性。这一发展趋势是由製药和农业领域对合成生物学应用日益增长的需求所驱动的。市场正朝着经济高效且扩充性的解决方案发展，这对于满足不断增长的高通量需求至关重要。在竞争激烈的市场中，主要企业正以最尖端科技为标竿来衡量自身产品，并透过创新实现差异化。法规结构，尤其是在北美和欧洲，透过规定合规性和品质标准，对塑造市场动态起着至关重要的作用。这些法规影响打入市场策略和营运实践。竞争格局的特点是策略联盟和併购，旨在扩展技术能力和市场覆盖范围。不断变化的监管环境既给市场参与企业带来了挑战，也带来了机会，这要求他们具备策略灵活性和合规应对力。

主要趋势和驱动因素：

由于几个关键趋势和驱动因素，高通量DNA合成市场正经历强劲成长。其中一个关键趋势是合成生物学的快速发展，这推动了对高通量DNA合成技术的需求。这些进步使得更复杂、更有效率的基因工程应用成为可能，促进了市场扩张。另一个趋势是高通量DNA合成在个人化医疗领域的应用日益广泛。这一趋势的驱动力在于对客製化治疗方法和诊断的需求不断增长，而这些需求需要精准快速的DNA合成能力。因此，医疗机构正在加速采用这些技术以改善患者的治疗效果。此外，生物製药研发的兴起也是市场的主要驱动力。生物製药公司正在利用高通量DNA合成来加速药物发现过程并获得竞争优势。这一点在新型生物製药和基因疗法的开发中尤其明显。此外，DNA合成成本的下降使得这些技术更容易被更广泛的产业所采用。成本的降低正在刺激各个领域的创新，例如农业领域，人们正在开发基因改造生物以应对粮食安全挑战。最后，主要参与者之间的策略联盟和伙伴关係正在推动市场成长。这些合作加速了技术进步，扩大了我们高通量DNA合成解决方案的应用范围，从而增强了我们的市场渗透率并创造了新的成长机会。

目录

第一章执行摘要

第二章 市集亮点

第三章 市场动态

  • 宏观经济分析
  • 市场趋势
  • 市场驱动因素
  • 市场机会
  • 市场限制
  • 复合年均成长率：成长分析
  • 影响分析
  • 新兴市场
  • 技术蓝图
  • 战略框架

第四章 细分市场分析

  • 市场规模及预测：依类型
    • 寡核苷酸合成
    • 基因合成
    • 客製化DNA合成
  • 市场规模及预测：依产品划分
    • 合成器
    • 试剂
    • 消耗品
  • 市场规模及预测：依服务划分
    • 基因编辑
    • 复製
    • 定序
  • 市场规模及预测：依技术划分
    • 固相合成
    • 基于晶片的合成
    • 酵素合成
  • 市场规模及预测：依组件划分
    • 酵素
    • 核苷酸
    • 缓衝
  • 市场规模及预测：依应用领域划分
    • 合成生物学
    • 基因工程
    • 分子诊断
    • 药物发现
  • 市场规模及预测：依类型
    • 液体
    • 冷冻干燥
  • 市场规模及预测：依最终用户划分
    • 生技公司
    • 製药公司
    • 学术研究机构
  • 市场规模及预测：依製程划分
    • 自动化合成
    • 手工排版

第五章 区域分析

  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 其他拉丁美洲
  • 亚太地区
    • 中国
    • 印度
    • 韩国
    • 日本
    • 澳洲
    • 台湾
    • 亚太其他地区
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 西班牙
    • 义大利
    • 其他欧洲
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非
    • 撒哈拉以南非洲
    • 其他中东和非洲地区

第六章 市场策略

  • 需求与供给差距分析
  • 贸易和物流限制
  • 价格、成本和利润率趋势
  • 市场渗透率
  • 消费者分析
  • 法规概述

第七章 竞争讯息

  • 市场定位
  • 市场占有率
  • 竞争基准
  • 主要企业的策略

第八章 公司简介

  • Twist Bioscience
  • Gen9
  • Genscript Biotech
  • Integrated DNA Technologies
  • DNA Script
  • Evonetix
  • Telesis Bio
  • Camena Bioscience
  • Nuclera
  • Ansa Biotechnologies
  • Molecular Assemblies
  • Ori Ciro Genomics
  • Gene Art
  • ATUM
  • Synbio Technologies
  • Arbor Biosciences
  • Enzymatics
  • Custom Array
  • Bio Basic
  • Bio Cat

第九章：关于我们

简介目录
Product Code: GIS10977

High Throughput DNA Synthesis Market is anticipated to expand from $327.6 million in 2024 to $930.2 million by 2034, growing at a CAGR of approximately 11.4%. The High Throughput DNA Synthesis Market encompasses technologies enabling rapid, cost-effective production of large DNA sequences. It supports synthetic biology, drug discovery, and genetic research by offering scalable and precise synthesis. Driven by advancements in automation and bioinformatics, this market addresses the increasing demand for custom DNA constructs, facilitating innovations in healthcare, agriculture, and industrial biotechnology.

The High Throughput DNA Synthesis Market is experiencing robust growth, fueled by advancements in synthetic biology and genetic engineering. The oligonucleotide synthesis segment is the top performer, driven by its applications in therapeutics and diagnostics. Gene synthesis follows as the second highest performing sub-segment, benefiting from increased demand for personalized medicine and research in genomics. Automation technologies are transforming the market, enhancing efficiency and reducing error rates in DNA synthesis processes. Custom DNA synthesis services are gaining prominence, catering to the specific needs of research institutions and biotech firms. The pharmaceutical and biotechnology sectors are major contributors to market expansion, leveraging DNA synthesis for drug development and genetic research. Innovative platforms for high-throughput synthesis are emerging, offering scalable solutions for large-scale projects. Investment in R&D is accelerating, fostering the development of novel synthesis techniques and expanding the market's potential. The integration of AI and machine learning is expected to further revolutionize the industry.

Market Segmentation
TypeOligonucleotide Synthesis, Gene Synthesis, Custom DNA Synthesis
ProductSynthesizers, Reagents, Consumables
ServicesGene Editing, Cloning, Sequencing
TechnologySolid-phase Synthesis, Chip-based Synthesis, Enzymatic Synthesis
ComponentEnzymes, Nucleotides, Buffers
ApplicationSynthetic Biology, Genetic Engineering, Molecular Diagnostics, Drug Discovery
FormLiquid, Lyophilized
End UserBiotechnology Companies, Pharmaceutical Companies, Academic and Research Institutions
ProcessAutomated Synthesis, Manual Synthesis

The High Throughput DNA Synthesis Market is experiencing a dynamic shift with significant market share held by leading biotech firms. The landscape is defined by competitive pricing strategies and a surge in innovative product launches. New entrants and established players are unveiling advanced synthesis technologies, enhancing speed and accuracy. This evolution is driven by the increasing demand for synthetic biology applications in pharmaceuticals and agriculture. The market is witnessing a trend towards cost-effective, scalable solutions, which are pivotal in addressing the growing need for high-throughput capabilities. In the realm of competition, major companies are benchmarking their offerings against cutting-edge technologies, striving for differentiation through innovation. Regulatory frameworks, particularly in North America and Europe, are critical in shaping market dynamics, dictating compliance and quality standards. These regulations influence market entry strategies and operational practices. The competitive landscape is characterized by strategic alliances and mergers, aimed at expanding technological capabilities and market reach. As regulatory landscapes evolve, they present both challenges and opportunities for market participants, necessitating strategic agility and compliance prowess.

Geographical Overview:

The High Throughput DNA Synthesis Market is witnessing remarkable growth across diverse regions, each exhibiting unique characteristics. North America leads with its advanced biotechnology infrastructure and substantial investments in synthetic biology. The presence of leading biotech firms and research institutions propels the market. Europe follows, driven by strong government support for genomics research and a robust pharmaceutical industry. In Asia Pacific, the market is expanding rapidly due to increasing demand for personalized medicine and advancements in genetic engineering. Countries like China and India are emerging as significant players, with substantial investments in biotechnology. Latin America and the Middle East & Africa are nascent markets with growing potential. In Latin America, the focus is on agricultural biotechnology, while the Middle East & Africa are recognizing the importance of DNA synthesis in healthcare innovation and genetic research. These regions are poised for growth as investments in biotechnology infrastructure increase.

Global tariffs and geopolitical tensions are significantly influencing the High Throughput DNA Synthesis Market. Japan and South Korea are increasingly investing in local biotechnological advancements to mitigate reliance on imported reagents, while China accelerates its self-reliance strategy amidst export restrictions. Taiwan, with its robust tech manufacturing capabilities, remains pivotal yet vulnerable due to its geopolitical positioning. The parent market, driven by the burgeoning demand for personalized medicine and synthetic biology, is experiencing robust growth globally. By 2035, the market is expected to thrive, propelled by innovation and strategic regional collaborations. However, ongoing Middle East conflicts could disrupt global supply chains and elevate energy prices, indirectly impacting operational costs and timelines within the DNA synthesis sector.

Key Trends and Drivers:

The High Throughput DNA Synthesis Market is experiencing robust growth due to several key trends and drivers. One significant trend is the rapid advancements in synthetic biology, which are fueling demand for high throughput DNA synthesis technologies. These advancements are enabling more complex and efficient genetic engineering applications, driving market expansion. Another trend is the increasing application of high throughput DNA synthesis in personalized medicine. This trend is driven by the growing demand for tailored therapeutics and diagnostics, which require precise and rapid DNA synthesis capabilities. Consequently, healthcare providers are increasingly adopting these technologies to enhance patient outcomes. Moreover, the rise of biopharmaceutical research and development is a major market driver. Biopharmaceutical companies are leveraging high throughput DNA synthesis to accelerate drug discovery processes, thereby increasing their competitive edge. This is particularly evident in the development of novel biologics and gene therapies. Additionally, the declining cost of DNA synthesis is making these technologies more accessible to a broader range of industries. This cost reduction is spurring innovation across sectors such as agriculture, where genetically modified organisms are being developed to address food security challenges. Finally, strategic collaborations and partnerships among key players are driving market growth. These alliances are facilitating technological advancements and expanding the reach of high throughput DNA synthesis solutions, thereby enhancing market penetration and creating new opportunities for growth.

Research Scope:

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

  • 1.1 Market Size and Forecast
  • 1.2 Market Overview
  • 1.3 Market Snapshot
  • 1.4 Regional Snapshot
  • 1.5 Strategic Recommendations
  • 1.6 Analyst Notes

2 Market Highlights

  • 2.1 Key Market Highlights by Type
  • 2.2 Key Market Highlights by Product
  • 2.3 Key Market Highlights by Services
  • 2.4 Key Market Highlights by Technology
  • 2.5 Key Market Highlights by Component
  • 2.6 Key Market Highlights by Application
  • 2.7 Key Market Highlights by Form
  • 2.8 Key Market Highlights by End User
  • 2.9 Key Market Highlights by Process

3 Market Dynamics

  • 3.1 Macroeconomic Analysis
  • 3.2 Market Trends
  • 3.3 Market Drivers
  • 3.4 Market Opportunities
  • 3.5 Market Restraints
  • 3.6 CAGR Growth Analysis
  • 3.7 Impact Analysis
  • 3.8 Emerging Markets
  • 3.9 Technology Roadmap
  • 3.10 Strategic Frameworks
    • 3.10.1 PORTER's 5 Forces Model
    • 3.10.2 ANSOFF Matrix
    • 3.10.3 4P's Model
    • 3.10.4 PESTEL Analysis

4 Segment Analysis

  • 4.1 Market Size & Forecast by Type (2020-2035)
    • 4.1.1 Oligonucleotide Synthesis
    • 4.1.2 Gene Synthesis
    • 4.1.3 Custom DNA Synthesis
  • 4.2 Market Size & Forecast by Product (2020-2035)
    • 4.2.1 Synthesizers
    • 4.2.2 Reagents
    • 4.2.3 Consumables
  • 4.3 Market Size & Forecast by Services (2020-2035)
    • 4.3.1 Gene Editing
    • 4.3.2 Cloning
    • 4.3.3 Sequencing
  • 4.4 Market Size & Forecast by Technology (2020-2035)
    • 4.4.1 Solid-phase Synthesis
    • 4.4.2 Chip-based Synthesis
    • 4.4.3 Enzymatic Synthesis
  • 4.5 Market Size & Forecast by Component (2020-2035)
    • 4.5.1 Enzymes
    • 4.5.2 Nucleotides
    • 4.5.3 Buffers
  • 4.6 Market Size & Forecast by Application (2020-2035)
    • 4.6.1 Synthetic Biology
    • 4.6.2 Genetic Engineering
    • 4.6.3 Molecular Diagnostics
    • 4.6.4 Drug Discovery
  • 4.7 Market Size & Forecast by Form (2020-2035)
    • 4.7.1 Liquid
    • 4.7.2 Lyophilized
  • 4.8 Market Size & Forecast by End User (2020-2035)
    • 4.8.1 Biotechnology Companies
    • 4.8.2 Pharmaceutical Companies
    • 4.8.3 Academic and Research Institutions
  • 4.9 Market Size & Forecast by Process (2020-2035)
    • 4.9.1 Automated Synthesis
    • 4.9.2 Manual Synthesis

5 Regional Analysis

  • 5.1 Global Market Overview
  • 5.2 North America Market Size (2020-2035)
    • 5.2.1 United States
      • 5.2.1.1 Type
      • 5.2.1.2 Product
      • 5.2.1.3 Services
      • 5.2.1.4 Technology
      • 5.2.1.5 Component
      • 5.2.1.6 Application
      • 5.2.1.7 Form
      • 5.2.1.8 End User
      • 5.2.1.9 Process
    • 5.2.2 Canada
      • 5.2.2.1 Type
      • 5.2.2.2 Product
      • 5.2.2.3 Services
      • 5.2.2.4 Technology
      • 5.2.2.5 Component
      • 5.2.2.6 Application
      • 5.2.2.7 Form
      • 5.2.2.8 End User
      • 5.2.2.9 Process
    • 5.2.3 Mexico
      • 5.2.3.1 Type
      • 5.2.3.2 Product
      • 5.2.3.3 Services
      • 5.2.3.4 Technology
      • 5.2.3.5 Component
      • 5.2.3.6 Application
      • 5.2.3.7 Form
      • 5.2.3.8 End User
      • 5.2.3.9 Process
  • 5.3 Latin America Market Size (2020-2035)
    • 5.3.1 Brazil
      • 5.3.1.1 Type
      • 5.3.1.2 Product
      • 5.3.1.3 Services
      • 5.3.1.4 Technology
      • 5.3.1.5 Component
      • 5.3.1.6 Application
      • 5.3.1.7 Form
      • 5.3.1.8 End User
      • 5.3.1.9 Process
    • 5.3.2 Argentina
      • 5.3.2.1 Type
      • 5.3.2.2 Product
      • 5.3.2.3 Services
      • 5.3.2.4 Technology
      • 5.3.2.5 Component
      • 5.3.2.6 Application
      • 5.3.2.7 Form
      • 5.3.2.8 End User
      • 5.3.2.9 Process
    • 5.3.3 Rest of Latin America
      • 5.3.3.1 Type
      • 5.3.3.2 Product
      • 5.3.3.3 Services
      • 5.3.3.4 Technology
      • 5.3.3.5 Component
      • 5.3.3.6 Application
      • 5.3.3.7 Form
      • 5.3.3.8 End User
      • 5.3.3.9 Process
  • 5.4 Asia-Pacific Market Size (2020-2035)
    • 5.4.1 China
      • 5.4.1.1 Type
      • 5.4.1.2 Product
      • 5.4.1.3 Services
      • 5.4.1.4 Technology
      • 5.4.1.5 Component
      • 5.4.1.6 Application
      • 5.4.1.7 Form
      • 5.4.1.8 End User
      • 5.4.1.9 Process
    • 5.4.2 India
      • 5.4.2.1 Type
      • 5.4.2.2 Product
      • 5.4.2.3 Services
      • 5.4.2.4 Technology
      • 5.4.2.5 Component
      • 5.4.2.6 Application
      • 5.4.2.7 Form
      • 5.4.2.8 End User
      • 5.4.2.9 Process
    • 5.4.3 South Korea
      • 5.4.3.1 Type
      • 5.4.3.2 Product
      • 5.4.3.3 Services
      • 5.4.3.4 Technology
      • 5.4.3.5 Component
      • 5.4.3.6 Application
      • 5.4.3.7 Form
      • 5.4.3.8 End User
      • 5.4.3.9 Process
    • 5.4.4 Japan
      • 5.4.4.1 Type
      • 5.4.4.2 Product
      • 5.4.4.3 Services
      • 5.4.4.4 Technology
      • 5.4.4.5 Component
      • 5.4.4.6 Application
      • 5.4.4.7 Form
      • 5.4.4.8 End User
      • 5.4.4.9 Process
    • 5.4.5 Australia
      • 5.4.5.1 Type
      • 5.4.5.2 Product
      • 5.4.5.3 Services
      • 5.4.5.4 Technology
      • 5.4.5.5 Component
      • 5.4.5.6 Application
      • 5.4.5.7 Form
      • 5.4.5.8 End User
      • 5.4.5.9 Process
    • 5.4.6 Taiwan
      • 5.4.6.1 Type
      • 5.4.6.2 Product
      • 5.4.6.3 Services
      • 5.4.6.4 Technology
      • 5.4.6.5 Component
      • 5.4.6.6 Application
      • 5.4.6.7 Form
      • 5.4.6.8 End User
      • 5.4.6.9 Process
    • 5.4.7 Rest of APAC
      • 5.4.7.1 Type
      • 5.4.7.2 Product
      • 5.4.7.3 Services
      • 5.4.7.4 Technology
      • 5.4.7.5 Component
      • 5.4.7.6 Application
      • 5.4.7.7 Form
      • 5.4.7.8 End User
      • 5.4.7.9 Process
  • 5.5 Europe Market Size (2020-2035)
    • 5.5.1 Germany
      • 5.5.1.1 Type
      • 5.5.1.2 Product
      • 5.5.1.3 Services
      • 5.5.1.4 Technology
      • 5.5.1.5 Component
      • 5.5.1.6 Application
      • 5.5.1.7 Form
      • 5.5.1.8 End User
      • 5.5.1.9 Process
    • 5.5.2 France
      • 5.5.2.1 Type
      • 5.5.2.2 Product
      • 5.5.2.3 Services
      • 5.5.2.4 Technology
      • 5.5.2.5 Component
      • 5.5.2.6 Application
      • 5.5.2.7 Form
      • 5.5.2.8 End User
      • 5.5.2.9 Process
    • 5.5.3 United Kingdom
      • 5.5.3.1 Type
      • 5.5.3.2 Product
      • 5.5.3.3 Services
      • 5.5.3.4 Technology
      • 5.5.3.5 Component
      • 5.5.3.6 Application
      • 5.5.3.7 Form
      • 5.5.3.8 End User
      • 5.5.3.9 Process
    • 5.5.4 Spain
      • 5.5.4.1 Type
      • 5.5.4.2 Product
      • 5.5.4.3 Services
      • 5.5.4.4 Technology
      • 5.5.4.5 Component
      • 5.5.4.6 Application
      • 5.5.4.7 Form
      • 5.5.4.8 End User
      • 5.5.4.9 Process
    • 5.5.5 Italy
      • 5.5.5.1 Type
      • 5.5.5.2 Product
      • 5.5.5.3 Services
      • 5.5.5.4 Technology
      • 5.5.5.5 Component
      • 5.5.5.6 Application
      • 5.5.5.7 Form
      • 5.5.5.8 End User
      • 5.5.5.9 Process
    • 5.5.6 Rest of Europe
      • 5.5.6.1 Type
      • 5.5.6.2 Product
      • 5.5.6.3 Services
      • 5.5.6.4 Technology
      • 5.5.6.5 Component
      • 5.5.6.6 Application
      • 5.5.6.7 Form
      • 5.5.6.8 End User
      • 5.5.6.9 Process
  • 5.6 Middle East & Africa Market Size (2020-2035)
    • 5.6.1 Saudi Arabia
      • 5.6.1.1 Type
      • 5.6.1.2 Product
      • 5.6.1.3 Services
      • 5.6.1.4 Technology
      • 5.6.1.5 Component
      • 5.6.1.6 Application
      • 5.6.1.7 Form
      • 5.6.1.8 End User
      • 5.6.1.9 Process
    • 5.6.2 United Arab Emirates
      • 5.6.2.1 Type
      • 5.6.2.2 Product
      • 5.6.2.3 Services
      • 5.6.2.4 Technology
      • 5.6.2.5 Component
      • 5.6.2.6 Application
      • 5.6.2.7 Form
      • 5.6.2.8 End User
      • 5.6.2.9 Process
    • 5.6.3 South Africa
      • 5.6.3.1 Type
      • 5.6.3.2 Product
      • 5.6.3.3 Services
      • 5.6.3.4 Technology
      • 5.6.3.5 Component
      • 5.6.3.6 Application
      • 5.6.3.7 Form
      • 5.6.3.8 End User
      • 5.6.3.9 Process
    • 5.6.4 Sub-Saharan Africa
      • 5.6.4.1 Type
      • 5.6.4.2 Product
      • 5.6.4.3 Services
      • 5.6.4.4 Technology
      • 5.6.4.5 Component
      • 5.6.4.6 Application
      • 5.6.4.7 Form
      • 5.6.4.8 End User
      • 5.6.4.9 Process
    • 5.6.5 Rest of MEA
      • 5.6.5.1 Type
      • 5.6.5.2 Product
      • 5.6.5.3 Services
      • 5.6.5.4 Technology
      • 5.6.5.5 Component
      • 5.6.5.6 Application
      • 5.6.5.7 Form
      • 5.6.5.8 End User
      • 5.6.5.9 Process

6 Market Strategy

  • 6.1 Demand-Supply Gap Analysis
  • 6.2 Trade & Logistics Constraints
  • 6.3 Price-Cost-Margin Trends
  • 6.4 Market Penetration
  • 6.5 Consumer Analysis
  • 6.6 Regulatory Snapshot

7 Competitive Intelligence

  • 7.1 Market Positioning
  • 7.2 Market Share
  • 7.3 Competition Benchmarking
  • 7.4 Top Company Strategies

8 Company Profiles

  • 8.1 Twist Bioscience
    • 8.1.1 Overview
    • 8.1.2 Product Summary
    • 8.1.3 Financial Performance
    • 8.1.4 SWOT Analysis
  • 8.2 Gen9
    • 8.2.1 Overview
    • 8.2.2 Product Summary
    • 8.2.3 Financial Performance
    • 8.2.4 SWOT Analysis
  • 8.3 Genscript Biotech
    • 8.3.1 Overview
    • 8.3.2 Product Summary
    • 8.3.3 Financial Performance
    • 8.3.4 SWOT Analysis
  • 8.4 Integrated DNA Technologies
    • 8.4.1 Overview
    • 8.4.2 Product Summary
    • 8.4.3 Financial Performance
    • 8.4.4 SWOT Analysis
  • 8.5 DNA Script
    • 8.5.1 Overview
    • 8.5.2 Product Summary
    • 8.5.3 Financial Performance
    • 8.5.4 SWOT Analysis
  • 8.6 Evonetix
    • 8.6.1 Overview
    • 8.6.2 Product Summary
    • 8.6.3 Financial Performance
    • 8.6.4 SWOT Analysis
  • 8.7 Telesis Bio
    • 8.7.1 Overview
    • 8.7.2 Product Summary
    • 8.7.3 Financial Performance
    • 8.7.4 SWOT Analysis
  • 8.8 Camena Bioscience
    • 8.8.1 Overview
    • 8.8.2 Product Summary
    • 8.8.3 Financial Performance
    • 8.8.4 SWOT Analysis
  • 8.9 Nuclera
    • 8.9.1 Overview
    • 8.9.2 Product Summary
    • 8.9.3 Financial Performance
    • 8.9.4 SWOT Analysis
  • 8.10 Ansa Biotechnologies
    • 8.10.1 Overview
    • 8.10.2 Product Summary
    • 8.10.3 Financial Performance
    • 8.10.4 SWOT Analysis
  • 8.11 Molecular Assemblies
    • 8.11.1 Overview
    • 8.11.2 Product Summary
    • 8.11.3 Financial Performance
    • 8.11.4 SWOT Analysis
  • 8.12 Ori Ciro Genomics
    • 8.12.1 Overview
    • 8.12.2 Product Summary
    • 8.12.3 Financial Performance
    • 8.12.4 SWOT Analysis
  • 8.13 Gene Art
    • 8.13.1 Overview
    • 8.13.2 Product Summary
    • 8.13.3 Financial Performance
    • 8.13.4 SWOT Analysis
  • 8.14 ATUM
    • 8.14.1 Overview
    • 8.14.2 Product Summary
    • 8.14.3 Financial Performance
    • 8.14.4 SWOT Analysis
  • 8.15 Synbio Technologies
    • 8.15.1 Overview
    • 8.15.2 Product Summary
    • 8.15.3 Financial Performance
    • 8.15.4 SWOT Analysis
  • 8.16 Arbor Biosciences
    • 8.16.1 Overview
    • 8.16.2 Product Summary
    • 8.16.3 Financial Performance
    • 8.16.4 SWOT Analysis
  • 8.17 Enzymatics
    • 8.17.1 Overview
    • 8.17.2 Product Summary
    • 8.17.3 Financial Performance
    • 8.17.4 SWOT Analysis
  • 8.18 Custom Array
    • 8.18.1 Overview
    • 8.18.2 Product Summary
    • 8.18.3 Financial Performance
    • 8.18.4 SWOT Analysis
  • 8.19 Bio Basic
    • 8.19.1 Overview
    • 8.19.2 Product Summary
    • 8.19.3 Financial Performance
    • 8.19.4 SWOT Analysis
  • 8.20 Bio Cat
    • 8.20.1 Overview
    • 8.20.2 Product Summary
    • 8.20.3 Financial Performance
    • 8.20.4 SWOT Analysis

9 About Us

  • 9.1 About Us
  • 9.2 Research Methodology
  • 9.3 Research Workflow
  • 9.4 Consulting Services
  • 9.5 Our Clients
  • 9.6 Client Testimonials
  • 9.7 Contact Us